Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis

scientific article published on 2 August 2016

Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/NDT.S110613
P932PMC publication ID4977099
P698PubMed publication ID27536114

P2093author name stringLin Wang
Jie Zhang
Dan Sun
Dan Wang
Lijun Yu
Hongjing Wu
Jianqi Xiao
Xuerong Qiu
P2860cites workIs improvement in impaired cognition and depressive symptoms in post-stroke patients associated with recovery in activities of daily living?Q51903816
Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular DisordersQ69764184
A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese ratsQ80037913
1H-NMR-based metabolomics study of cerebral infarctionQ83809378
MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysisQ24632755
Post-stroke depression: Prevalence and relationship with disability in chronic stroke survivorsQ34075851
Metabolomics: a global biochemical approach to drug response and diseaseQ34734298
Sex-specific urinary biomarkers for diagnosing bipolar disorderQ34757521
Poststroke depression and treatment effects on functional outcomesQ35732869
Potential metabolite markers of schizophrenia.Q36479055
Identification and validation of urinary metabolite biomarkers for major depressive disorderQ36508139
Assessment of depression after stroke: a comparison of different screening instrumentsQ37346806
Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.Q37733240
Screening for poststroke major depression: a meta-analysis of diagnostic validity studiesQ38079488
Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic ApproachQ38985361
Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.Q43187905
Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic strokeQ43901436
Systems biology: MetabonomicsQ47647280
A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression DiagnosisQ48050618
Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depressionQ48289603
Long-term incidence of depression and predictors of depressive symptoms in older stroke survivorsQ48409334
Serotonin transporter gene polymorphism in Chinese patients with poststroke depression: a case-control study.Q48886271
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesNMR spectroscopyQ10359898
P407language of work or nameEnglishQ1860
P304page(s)1919-1925
P577publication date2016-08-02
P1433published inNeuropsychiatric Disease and TreatmentQ15716332
P1476titleDiscriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis
P478volume12

Reverse relations

cites work (P2860)
Q47562585Hippocampal metabolic differences implicate distinctions between physical and psychological stress in four rat models of depression
Q94560996Metabonomic Profile and Signaling Pathway Prediction of Depression-Associated Suicidal Behavior
Q90650069Poststroke Depression Biomarkers: A Narrative Review

Search more.